RUNX1预测预后不佳,并且与清细胞癌中瘤进展相关
Jing Ma1, Shaofei He2, Mingyang Li1
1State Key Laboratory of Cancer Biology, Department of Pathology, Xijing Hospital and School of Basic Medicine, Fourth Military Medical University, Xi'an, Shaanxi Province, China.
与Runt相关的转录因子1 (RUNX1) 在清细胞癌中过度表达,与患者存活时间缩短有关. 这表明RUNX1是一个不良的预后因素,也是癌的潜在治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 与Runt相关的转录因子1 (RUNX1) 是一个关键的转录因子,在细胞癌 (RCC) 的发展中起着未知的作用.
- 在癌症进展中的RUNX1的功能及其在RCC中的临床意义仍然需要阐明.
研究的目的:
- 研究RUNX1在清细胞癌 (ccRCC) 发病过程中的作用.
- 在RCC患者中确定RUNX1表达的预后值.
主要方法:
- 在100名RCC患者组织和15个配对的正常脏组织中,通过免疫组织化学和西部涂抹分析RUNX1表达.
- 在体外测试 (CCK-8,伤口愈合,透洞) 评估了RUNX1对细胞增殖,迁移和入侵的影响.
- 在体内瘤发生研究使用异种移植模型,在786-O细胞系中进行RUNX1敲除.
主要成果:
- TCGA数据库显示,脏清细胞癌 (KIRC) 的RUNX1表达升高.
- 在RCC患者中,较高的RUNX1表达与较短的整体存活 (OS) 相关联.
- RUNX1的过度表达促进了ccRCC细胞的增殖,迁移和入侵,而敲击抑制了这些过程和瘤生长.
结论:
- 在清晰细胞癌中,RUNX1是显著的不良预后因素.
- 在ccRCC治疗中,RUNX1代表了一个潜在的新型治疗点.
更多相关视频
09:16Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
相关概念视频
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
lncRNA - Long Non-coding RNAs
Non-LTR Retrotransposons
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Abnormal Proliferation
